2017 American Transplant Congress » Poster Session B: Bacteria, Fungi, Parasites

6:00pm-7:00pm

Clostridium difficile Infection in Intestinal Transplant Recipients.

V. Goldenberg,¹ A. Berbel,² J. Camargo,¹ J. Simkins.¹

6:00pm-7:00pm

Antibiotic Conservatorship in Orthotopic Liver Transplantation.

J. Yee,² D. Clark,² R. Hogen,^1,2 K. Dhanireddy,¹ S. Biswas,² J. Cobb,² K. Matsushima,² D. Grabo,² A. Strumwasser.²

6:00pm-7:00pm

Clinical Experience with Novel Cephalosporin/Beta-Lactamase Inhibitor Combinations in the Treatment of Multidrug Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplant Recipients.

P. Nambiar,¹ K. Brizendine,¹ V. Athans,² E. Cober.¹

6:00pm-7:00pm

Describing the Effects of the Antibiotic Regimen Immediate Post Multi-Visceral Transplant in the Pediatric Population on the Time to First Serious Bacterial Infection.

B. Chatani,¹ J. Garcia,² C. Biaggi,² T. Beduschi,³ A. Tekin,³ R. Vianna,⁴ I. Gonzalez.⁵

6:00pm-7:00pm

Does an Indeterminate Result on Pre-Transplantation Tuberculosis Interferon Gamma Release Assay Predict Risk for Post-Transplantation Infection or Rejection?

A. Zimmer,¹ R. Razonable.²

6:00pm-7:00pm

Efficacy of Trimethoprim-Sulfamethoxazole Prophylaxis for Nocardia in Solid Organ Transplant Recipients (SOTRs): Systematic Review and Meta-Analysis.

A. Alsharidi,¹ A. Gonzalez,² C. Rotstein,³ A. Humar,³ D. Kumar,³ S. Husain.³

6:00pm-7:00pm

Epidemiology and Clinical Outcomes of Mycobacterium tuberculosis in Liver Transplant Recipients in an Intermediate Tuberculosis-Endemic Area.

S. Kim,¹ Y. Kim,¹ J. Choi,² S. Yoon,² J. Kim,³ I. Moon,³ Y. Yoo,³ D. Kim.³

6:00pm-7:00pm

Evaluation of Vancomycin Resistant Enterococcus (VRE) Colonization and Infection Rate in Adult Liver Transplant Patients.

E. Aldag,¹ G. Fouth,¹ R. Pedersen,¹ L. Fehrenbacher,^1,2 A. Sahajpal,¹ V. Gunabushanam,¹ D. Kramer.¹

6:00pm-7:00pm

Factors in Association with Sepsis Differ Between Simultaneous Pancreas/Kidney and Single Kidney Transplant Recipients.

T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2

6:00pm-7:00pm

Identifying Risks and Screening Deceased Organ Donors in the UK for Trypanosoma cruzi .

I. Ushiro-Lumb,^1,2 M. Webster,¹ A. Kitchen.¹

6:00pm-7:00pm

Impact of Antibiotic Treatment Duration for Symptomatic Lower Urinary Tract Infections in Kidney Transplant Recipients.

S. Shaikh, S. Tischer, D. Kaul, A. Naik, M. Miceli, K. Gregg, N. Leja, T. Patel.

6:00pm-7:00pm

Incidence and Clinical Outcomes of Mycobacterium tuberculosis Infections Following Renal Transplantation in Endemic Country.

K. Jutivorakool, J. Vanichanan, G. Suwanpimolkul, Y. Avihingsanon, N. Townamchai.

6:00pm-7:00pm

Incidence and Clinical Outcomes of Active Tuberculosis in Transplant Recipients from a Low Prevalence Region.

Y. Natori, A. Humar, S. Husain, D. Kumar.

6:00pm-7:00pm

Incidence of Fungal and Viral Infections Following Rituximab Use in Kidney Transplant Recipients.

L. Wong, M. Ison, C. Richardson, K. Cunningham, C. D'Agostino, C. Tseng, A. Shetty.

6:00pm-7:00pm

Increased Pro-Inflammatory and Decreased Interferon-Related Gene Expression in Older as Compared with Younger Kidney Transplant Recipients.

J. Schaenman, O. Beiard, E. Liang, T. Sidwell, V. Groysberg, M. Rosetti, B. Abdalla, E. Lum, S. Bunnapradist, T. Pham, G. Dannovitch, J. Veale, H. Gritsch, A. Karlamangla, S. Cole, E. Reed.

6:00pm-7:00pm

MicroRNAs and Long Non-Coding RNAs as Potential Novel Biomarkers in Transplanted Patients with Candida Infection.

A. Yang,¹ C. Zhou,² D. Li,³ W. Ju,¹ Z. Guo,¹ L. Wu,¹ A. Hu,¹ Y. Ma,¹ D. Wang,¹ X. Zhu,¹ X. He.¹

6:00pm-7:00pm

Outcomes Following Reduction of Immunosuppression in Solid Organ Transplant Recipients with Cryptococcosis.

P. Bryant,¹ P. Pappas,¹ C. Huisingh,¹ R. Mannon,¹ J. Locke,¹ K. Wille,¹ D. Eckhoff,¹ J. Tallaj,¹ J. Baddley.^1,2

6:00pm-7:00pm

Outcomes of Active Screening for Carbapenem-Resistant Enterobacteriaceae among Liver Transplant Recipients.

T. Bias,¹ G. Malat,¹ D. Lee,² S. Talluri,² K. Ranganna,² S. Epstein,² V. Patel,² S. Guy.³

6:00pm-7:00pm

Outcomes of Recurrent Clostridium difficile Infection in Solid Organ Transplant Recipients.

M. Shiotsuka, Y. Natori, D. Kumar, A. Humar, C. Rotstein, S. Husain.

6:00pm-7:00pm

Prevalence of Cutaneous Disease in Solid Organ Transplant Recipients: A 5-Year Study from a Medical -Surgical Transplant Dermatology Center.

R. Allawh, A. Weiffenbach, K. Nadhan, M. Abdelmalek, C. Cusack, C. Chung.

6:00pm-7:00pm

Risk Factors for Cryptococcal Disease in Transplant as Compared with Non-Transplant Patients: A Single Center Study.

O. Beaird,¹ O. Garner,² R. Humphries,² J. Schaenman.¹

6:00pm-7:00pm

Strongyloides Infection in Solid Organ Transplant Recipients: A Single Center Experience and Review of the Literature.

H. El Haddad,¹ V. Hemmige,¹ A. Sofjan,² T. Lasco,³ A. Restrepo.¹

6:00pm-7:00pm

TB Chemoprophylaxis Post Transplantation in West London.

Y. Al-Mula Abed,¹ R. Charif,² O. Kon,³ D. Taube.²

6:00pm-7:00pm

The Incidence and Outcomes of Fever of Unknown Origin After Pancreas Transplantation.

R. Klasek,¹ S. Kuten,¹ S. Patel,^1,3 D. Nguyen,¹ E. Graviss,¹ A. Gaber,¹ R. Knight.¹

6:00pm-7:00pm

Trends in Infection Among Kidney Transplant Recipients, 1999-2013.

S. Bae, C. Durand, L. Kucirka, S. DiBrito, R. Avery, J. Garonzik Wang, D. Segev.

6:00pm-7:00pm

Uromodulin and Toll-Like Receptor 4 Levels Predict Susceptibility to Bacterial Urinary Tract Infection After Renal Transplantation.

K. Stahl,¹ H. Lührs,¹ J. Schmitz,² I. Scheffner,¹ W. Gwinner,¹ J. Bräsen,² H. Haller,¹ M. Schiffer.¹

6:00pm-7:00pm

Vancomycin Prophylaxis for Prevention of Clostridium difficile Recurrence in Renal Transplant Patients.

L. Spliner,¹ J. Fose,¹ G. Leverson,² J. Smith,³ C. Saddler,³ M. Jorgenson.¹